David Courtman, Ph.D. · Scientist and Director of Biotherapeutics at the Ottawa Hospital Research Institute; Assistant Professor at the University of Ottawa; Chief Scientific Officer of Northern Therapeutics
Dr. Courtman is trained in cellular and molecular pathology and biophysics with, extensive expertise in the development of novel therapies for cardiovascular disease. He has a long standing interest in the development of novel cardiovascular biomaterials and the regulation of biological responses within the unique spatially-oriented matricellular environment of blood vessels.
Dr.Courtman has participated in the development of a number of cellular-based gene therapies for the treatment of cardiopulmonary disorders taking them from initial concept, through appropriate animal disease models, and into first-in-human clinical trials. He is currently directing the manufacturing of these cell products for trials treating patients suffering from pulmonary arterial hypertension, myocardial infarction, and sepsis.
He is a Scientist and Director of Biotherapeutics at the Ottawa Hospital Research Institute, Assistant Professor at the University of Ottawa, and Chief Scientific Officer of Northern Therapeutics.
- Read an interview with Dr. Courtman as he discusses academic perspectives on cell therapy, trial design and building partnerships